Vittoria Biotherapeutics is a startup based in the United States, 1 tracked investor.
Vittoria Biotherapeutics is a startup based in the United States. Brouky records 1 investor associated with the company.
Vittoria Biotherapeutics is a clinical-stage biotechnology company developing next-generation CAR T-cell therapies using its proprietary SENZA5 platform to treat oncology and immunology conditions.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.